RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
Open Access
- 23 June 2020
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (25) , 2387-2403
Abstract
Https://doi.org/10.18632/oncotarget.27630 Hee-Don Chae, Ritika Dutta, Bruce Tiu, Fieke W. Hoff, Benedetta Accordi, Valentina Serafin, Minyoung Youn, Min Huang, Nathan Sumarsono, Kara L. Davis, Norman...Keywords
This publication has 62 references indexed in Scilit:
- Microtubule attachment and spindle assembly checkpoint signalling at the kinetochoreNature Reviews Molecular Cell Biology, 2012
- Killing cells by targeting mitosisCell Death & Differentiation, 2012
- Small-molecule kinase inhibitors provide insight into Mps1 cell cycle functionNature Chemical Biology, 2010
- The RSK family of kinases: emerging roles in cellular signallingNature Reviews Molecular Cell Biology, 2008
- Death through a tragedy: mitotic catastropheCell Death & Differentiation, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- FGFR3 Activates RSK2 to Mediate Hematopoietic Transformation through Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK PathwayCancer Cell, 2007
- The spindle-assembly checkpoint in space and timeNature Reviews Molecular Cell Biology, 2007
- BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoformsin vitroandin vivoBiochemical Journal, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001